A review of the effects of dopaminergic agents in humans: implications for medication development.
Rothman
R B
RB
Laboratory of Clinical Psychopharmacology, National Institute on Drug Abuse Addiction Research Center, Baltimore, MD 21224, USA.
D003042:Cocaine / Q000494:pharmacology*; D015259:Dopamine Agents / Q000494:pharmacology*; D018491:Dopamine Agonists / Q000494:pharmacology; D018492:Dopamine Antagonists / Q000494:pharmacology; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology; D015195:Drug Design; D006801:Humans; D009294:Narcotics / Q000494:pharmacology*; D012054:Reinforcement, Psychology
D015259:Dopamine Agents; D018491:Dopamine Agonists; D018492:Dopamine Antagonists; D018765:Dopamine Uptake Inhibitors; D009294:Narcotics; D003042:Cocaine